EUVIMEDEUVIMED entdecken
Crossref

AHR suppresses cisplatin-induced apoptosis in ovarian cancer cells by regulating XIAP

Geng Shen, Surong Xu, Anqi Zhu, Zhipeng Zheng, Wei Chen, Songshan Jiang

Biochemical Pharmacology · 2025

DOI: 10.1016/j.bcp.2024.116640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2025. Verfasst von Geng Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, School of Life Sciences, Sun Yat-sen University, Guangzhou, China; School of Basic Medical Sciences, Guangzhou University of C…. Hauptthemen laut MEDLINE: X-Linked Inhibitor of Apoptosis Protein, Cisplatin, Ovarian Neoplasms, Apoptosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

X-linked inhibitor of apoptosis protein (XIAP) plays a crucial role in cisplatin-induced apoptosis in ovarian cancer, whereas the molecular mechanism of how its expression is dysregulated remains unclear. Here, we report that the aryl hydrocarbon receptor (AHR) acts as a competitive endogenous RNA (ceRNA) of XIAP and can regulate its expression. Overexpression of AHR 3'UTR decreased, while AHR knockdown increased, the cisplatin-induced apoptotic rate in ovarian cancer cells. We also found that one microRNA (miRNA), miR-142-5p, can bind to both AHR and XIAP 3'UTRs and regulate their expression levels. Furthermore, AHR 3'UTR and miR-142-5p can occupy the same Ago2 to form an RNA-induced silencing complex (RISC). In addition, we showed that the effect of AHR overexpression on cisplatin-induced apoptosis could be rescued by either XIAP siRNA or miR-142-5p mimic. Thus, our findings reveal important insights into the molecular mechanism underlying the dysregulation of XIAP in ovarian cancer, indicating that AHR serves as the ceRNA that competes miR-142-5p with XIAP and subsequently affects the platinum-based chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

X-Linked Inhibitor of Apoptosis ProteinCisplatinOvarian NeoplasmsApoptosisReceptors, Aryl HydrocarbonAntineoplastic AgentsHumansFemaleCell Line, TumorMicroRNAsBasic Helix-Loop-Helix ProteinsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

ApoptosisChemotherapyCompetitive endogenous RNA (ceRNA)Ovarian cancer

Substanzen

X-Linked Inhibitor of Apoptosis ProteinCisplatinReceptors, Aryl HydrocarbonAntineoplastic AgentsMicroRNAsBasic Helix-Loop-Helix ProteinsXIAP protein, humanAHR protein, humanMIRN142 microRNA, human

Autor:innen und Institutionen

  • Department of Biology, School of Life Sciences, Sun Yat-sen University, Guangzhou, China; School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Department of Gynecology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Department of Biology, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
  • Department of General Surgery, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Department of Gynecology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. Electronic address: 2624200814@qq.com.
  • Department of Biology, School of Life Sciences, Sun Yat-sen University, Guangzhou, China. Electronic address: jiangssh@mail.sysu.edu.cn.

Zitieren

APA

Shen, G., Xu, S., Zhu, A., Zheng, Z., Chen, W., & Jiang, S. (2025). AHR suppresses cisplatin-induced apoptosis in ovarian cancer cells by regulating XIAP. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2024.116640

Vancouver

Shen G, Xu S, Zhu A, Zheng Z, Chen W, Jiang S. AHR suppresses cisplatin-induced apoptosis in ovarian cancer cells by regulating XIAP. Biochemical Pharmacology. 2025. doi:10.1016/j.bcp.2024.116640

BibTeX
@article{Shen2025,
  author = {Shen, Geng and Xu, Surong and Zhu, Anqi and Zheng, Zhipeng and Chen, Wei and Jiang, Songshan},
  title = {AHR suppresses cisplatin-induced apoptosis in ovarian cancer cells by regulating XIAP},
  journal = {Biochemical Pharmacology},
  year = {2025},
  doi = {10.1016/j.bcp.2024.116640}
}
Kostenlos starten →